ARTICLE | Clinical News
Cambia diclofenac regulatory update
April 2, 2012 7:00 AM UTC
Health Canada approved Cambia diclofenac from Stellar's Tribute Pharmaceuticals subsidiary for the acute treatment of migraine attacks with or without aura in adults. The company plans to launch the p...